A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial

OBJECTIVE: The role of U300 glargine insulin for the inpatient management of type 2 diabetes (T2D) has not been determined. We compared the safety and efficacy of glargine U300 versus glargine U100 in noncritically ill patients with T2D. RESEARCH DESIGN AND METHODS: This prospective, open-label, ran...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Pasquel, Francisco J., Lansang, M. Cecilia, Khowaja, Ameer, Urrutia, M. Agustina, Cardona, Saumeth, Albury, Bonnie, Galindo, Rodolfo J., Fayfman, Maya, Davis, Georgia, Migdal, Alexandra, Vellanki, Priyathama, Peng, Limin, Umpierrez, Guillermo E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2020
Témata:
Emerging Therapies: Drugs and Regimens
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411278/
https://ncbi.nlm.nih.gov/pubmed/32273271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1940
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky